Informed Consent on Trial
By Daniel Cressey,
Nature News
| 01. 30. 2012
BRUSSELS- Informing clinical-trial participants of the risks they face is a cornerstone of modern medical research, and it is enshrined as a human right in international codes of ethics. But an influential group of ethicists and medical researchers warned at a meeting in Brussels last week that the process has become a box-ticking exercise focused more on offering legal protection to a trial’s organizer than actually protecting patients.
“We clearly identified there is an urgent need to do informed consent better,” says Ingrid Klingmann, chairman of the European Forum for Good Clinical Practice, a think tank based in Brussels and the organizer of the meeting. “The pressure is really huge on all those involved to better enable patients to understand the implications of their study participation, their benefits, risks and obligations.”
The European Clinical Trials Directive, which sets minimum standards for clinical trials conducted in the European Union’s member states, says that trial participants must be duly informed of the “nature, significance, implications and risks” of the clinical trial. Yet delegates at the meeting detailed a host of ways in...
Related Articles
By Priyanka Runwal, Chemical and Engineering News | 08.05.2024
Saritee Sanodiya, 26, has spent countless days wondering if she’ll ever live a “normal” life. Growing up, Sanodiya often missed school, frequenting the hospital for sudden, life-threatening drops in her hemoglobin levels and excruciating pain in her joints. High fever...
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Alcott Wei, South China Morning Post | 07.13.2024
China has banned all clinical research involving germline genome editing under a newly released ethics guideline.
Germline gene engineering relates to altering the DNA in sperm, eggs or early embryos to introduce changes that can be inherited.
“Any clinical research...
By Staff, Japan Times | 07.10.2024
Photo by Roméo A. on Unsplash
How did Japanese society, which was supposed to have transformed into a democracy after World War II, justify discrimination against people with disabilities and openly endorse eugenics?
This is a key question people may...